Movement Alert｜Incyte Falls 9.08% Overnight, Target Price Divergence Widens Ahead of Earnings

Market Focus10-19

On October 19, Incyte fell 9.08% Overnight, trading at $102.8/share, with turnover of $103.0.

The clearest recent catalyst was growing divergence in analyst target-price revisions ahead of the company’s October 29 earnings release, even though several firms had raised targets earlier and the broader analyst average remained above the latest trading level.

Recent updates showed Goldman Sachs lifting its target to $110 from $100 while keeping a Neutral rating, BofA raising its target to $136 from $124, Jefferies moving to $105 from $100 with Hold maintained, and RBC increasing to $99 from $95 with Sector Perform. The company’s next report is expected to show EPS of $-3.87, versus a prior quarter released on July 28 that had beaten expectations with EPS of 2.8, suggesting the current pullback reflects rising debate over earnings durability and valuation into the print.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment